Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality. Professor Bernd Rehm and Dr Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Centre for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable particulate vaccine. Professor Bernd Rehm The new vaccine modality is at proof-of-concept stage and in early development. To demonstrate this vaccine approach, it was tested with a more established Griffith vaccine against Strep A that is currently performing strongly in human clinical trials in Canada.

https://www.miragenews.com/griffith-on-cusp-of-new-vaccine-modality-1070927/

#miragenews